LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 62 filers reported holding LEGEND BIOTECH CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,463,608 | -4.6% | 81,340 | -1.9% | 0.01% | 0.0% |
| Q2 2023 | $5,724,105 | +61.0% | 82,922 | +12.5% | 0.01% | +50.0% |
| Q1 2023 | $3,554,730 | +10.4% | 73,719 | +14.3% | 0.00% | +33.3% |
| Q4 2022 | $3,219,391 | +13.4% | 64,491 | -7.3% | 0.00% | 0.0% |
| Q3 2022 | $2,839,000 | -55.5% | 69,591 | -40.0% | 0.00% | -57.1% |
| Q2 2022 | $6,385,000 | +29.2% | 116,079 | -14.6% | 0.01% | +75.0% |
| Q1 2022 | $4,941,000 | -3.5% | 135,978 | +23.8% | 0.00% | +33.3% |
| Q4 2021 | $5,119,000 | +500.8% | 109,824 | +552.0% | 0.00% | – |
| Q3 2021 | $852,000 | +44.4% | 16,843 | +17.2% | 0.00% | – |
| Q2 2021 | $590,000 | +23.4% | 14,377 | -12.8% | 0.00% | – |
| Q1 2021 | $478,000 | +28.8% | 16,493 | +25.2% | 0.00% | – |
| Q4 2020 | $371,000 | – | 13,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |